NHS National Generic Pharmaceuticals Wave 13
A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 14 Jan 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: Please refer to document 03, schedule 8 in the ITO documents for the list of Purchasing Points
Geochart for 1 buyers and 192 suppliers
1 buyer
131 suppliers
- Martindale Pharma Romford
- Sandoz Camberley
- Teva Castleford
- Drreddys Laboratories Beverley
- Accord Barnstaple
- Pfizer Kent
- Allergan Marlow
- Medreich Weybridge
- Ennogen Healthcare Dartford
- Glaxosmithkline London
- Syri Ruislip
- Medac Pharma Stirling
- Rosemont Pharmaceuticals Leeds
- Mercury Pharmaceuticals London
- Selective Supplies London
- Consilient Health Richmond upon Thames
- Glenmark Pharmaceuticals Europe Watford
- Healthcare Pharma Haslemere
- Thornton & Ross Huddersfield
- Mylan Potters Bar
- Macleods Pharma Billingham
- Wockhardt Wrexham
- DR Falk Pharma Bourne End
- Desitin Pharma Woking
- Torrent Pharma Crawley
- Fontus Health Walsall
- Aspire Pharma Godalming
- Amarox Harrow
- Aop Orphan Weybridge
- Ranbaxy Hayes
- Arcadia Pharma Fforestfach
- Derma Ouseburn
- Zista Pharma Stevenage
- Aspen Pharmacare Maidenhead
- Manx Healthcare Warwick
- Colonis Pharma London
- Roche Products Welwyn Garden City
- Profile Pharma Chichester
- Zentiva Pharma London
- Organon Pharmaceuticals London
- Day Lewis Medical Croydon
- Logixx Pharma Reading
- Lundbeck Watford
- Napp Pharmaceuticals Cambridge
- Bayer Reading
- Morningside Pharmaeuticals Northampton
- Dexcel Pharma Daventry
- CST Pharma Walsall
- Cipla Eu Addlestone
- Relonchem Widnes
- RPH Pharmaceuticals Cheadle
- Drugsrus Northwood
- Ferring Pharmaceuticals West Drayton
- Milpharm South Ruislip
- Crescent Pharma Basingstoke
- Roma Pharmaceuticals Burton upon Trent
- Kyowa Kirin Galashiels
- Brown & Burk Hounslow
- Lupin Healthcare Slough
- Alliance Pharmaceuticals Chippenham
- Bristol Laboratories Berkhamsted
- Aristo Pharma Ely
- Synchrony Stevenage
- Alissa Healthcare Research Fareham
- Neon Healthcare Hertford
- Aventis Pharma Reading
- Acium Stevenage
- Ascend Laboratories London
- Rivopharm London
- Strides Pharma Watford
- V Pharma Kent
- Upjohn Kent
- Noumed Life Sciences Maidenhead
- Atnahs Pharma London
- Phoenix Lab County Meath
- Sciecure Pharma Guildford
- Intrapharm Laboratories Maidenhead
- Typharm Norwich
- Oralieve Luton
- Flynn Pharma County Dublin
- Takeda London
- Beaumont Pharma Burnley
- Tillomed Laboratories Luton
- Focus Pharmaceuticals London
- Galen Co Armagh
- Clydesdale Pharma Tadley
- Medley Pharma Bootle
- Mibe Pharma London
- Transdermal Berkshire
- Ipca Laboratories Sunderland
- Necessity Supplies Northolt
- Ferndale Pharmaceuticals Wetherby
- Merck Sharpe & Dohme London
- Hameln Pharma Gloucester
- Nexcape Pharmaceuticals London
- Fresenius Kabi Runcorn
- Laboratorio Reig Jofre Bideford
- Kent Pharma Heathrow
- Bowmed Ibisqus Manchester
- Panpharma Liverpool
- Kensington Pharma Preston
- Thea Pharmaceuticals Keele
- Stragen Horsham
- B Braun Medical Sheffield
- Pierre Fabre London
- Macure Pharma Aps Copenhagen
- Waverley Pharma Europe County Dublin
- Baxter Healthcare Thetford
- Recordati Rare Diseases Maidenhead
- Flexipharm Austrading Bourne End
- Leo Pharma Hurley
- Aguettant Bristol
- Torbay Pharmaceuticals Paignton
- Pari London
- Seacross Pharmaceuticals London
- Altan Pharma County Dublin
- Lucane Pharma Ankeveen
- Norgine Pharmaceuticals Uxbridge
- Mip Pharma Blieskastel Niederwuerzbach
- Sobi Swedish Orphan Biovitrum Great Abington
- Tetris Pharma Northampton
- Sintetica London
- Alturix Milton Keynes
- Euro Link Pharma Luton
- Vantage Pharmaceuticals Hemel Hempstead
- Chiesi Manchester
- PM Pharma Norwich
- Correvio Bielefeld
- Waymade London
- Recordati Pharmaceuticals Bracknell
- Northumbria Pharma County Durham
Description
Potential periods of call-offs under the framework agreement:Transition (Everolimus)CESW: 1 March 2022 – 30 September 2023 (19 months)LSNE: 1 March 2022 – 31 January 2023 (11 months)NWLN: 1 March 2022 – 31 January 2023 (11 months)Oral Products plus non-parenteralsAll Regions: 1 March 2022 - 31 May 2024 (27 months)Hospital Only ProductsCESW: 1 February 2022 – 30 September 2023 (20 months)LSNE: 1 February 2022 – 31 May 2024 (28 months)NWLN: 1 February 2022 – 31 January 2023 (12 months)
Lot Division
| 1 | CM/PHG/17/5532/00 Transition (Everolimus) Invitation to offer for NHS National Generic Pharmaceuticals Wave 13Offer reference number: CM/PHG/17/5532Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.Potential periods of call-offs under the framework agreement:Transition (Everolimus)CESW: 1 March 2022 … – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 2 | CM/PHG/17/5532/01 Oral Products plus non-parenterals Invitation to offer for NHS National Generic Pharmaceuticals Wave 13Offer reference number: CM/PHG/17/5532Period of framework agreement:The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.Potential periods of call-offs under the framework agreement:Transition (Everolimus)CESW: 1 March 2022 … – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 3 | CM/PHG/17/5532/02 Hospital Only Products Invitation to offer for NHS National Generic Pharmaceuticals Wave 13Offer reference number: CM/PHG/17/5532Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.Potential periods of call-offs under the framework agreement:Transition (Everolimus)CESW: 1 March 2022 … – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
Award Detail
| 1 | Martindale Pharma (Romford)
|
| 2 | Sandoz (Camberley)
|
| 3 | Teva (Castleford)
|
| 4 | Drreddys Laboratories (Beverley)
|
| 5 | Accord (Barnstaple)
|
| 6 | Pfizer (Kent)
|
| 7 | Allergan (Marlow)
|
| 8 | Medreich (Weybridge)
|
| 9 | Ennogen Healthcare (Dartford)
|
| 10 | Glaxosmithkline (London)
|
| 11 | Syri (Ruislip)
|
| 12 | Medac Pharma (Stirling)
|
| 13 | Martindale Pharma (Romford)
|
| 14 | Rosemont Pharmaceuticals (Leeds)
|
| 15 | Mercury Pharmaceuticals (London)
|
| 16 | Selective Supplies (London)
|
| 17 | Consilient Health (Richmond upon Thames)
|
| 18 | Sandoz (Camberley)
|
| 19 | Glenmark Pharmaceuticals Europe (Watford)
|
| 20 | Healthcare Pharma (Haslemere)
|
| 21 | Thornton & Ross (Huddersfield)
|
| 22 | Mylan (Potters Bar)
|
| 23 | Macleods Pharma (Billingham)
|
| 24 | Wockhardt (Wrexham)
|
| 25 | DR Falk Pharma (Bourne End)
|
| 26 | Desitin Pharma (Woking)
|
| 27 | Torrent Pharma (Crawley)
|
| 28 | Fontus Health (Walsall)
|
| 29 | Aspire Pharma (Godalming)
|
| 30 | Teva (Castleford)
|
| 31 | Amarox (Harrow)
|
| 32 | Aop Orphan (Weybridge)
|
| 33 | Ranbaxy (Hayes)
|
| 34 | Arcadia Pharma (Fforestfach)
|
| 35 | Derma (Ouseburn)
|
| 36 | Zista Pharma (Stevenage)
|
| 37 | Drreddys Laboratories (Beverley)
|
| 38 | Aspen Pharmacare (Maidenhead)
|
| 39 | Manx Healthcare (Warwick)
|
| 40 | Colonis Pharma (London)
|
| 41 | Roche Products (Welwyn Garden City)
|
| 42 | Profile Pharma (Chichester)
|
| 43 | Zentiva Pharma (London)
|
| 44 | Organon Pharmaceuticals (London)
|
| 45 | Day Lewis Medical (Croydon)
|
| 46 | Logixx Pharma (Reading)
|
| 47 | Lundbeck (Watford)
|
| 48 | Napp Pharmaceuticals (Cambridge)
|
| 49 | Bayer (Reading)
|
| 50 | Morningside Pharmaeuticals (Northampton)
|
| 51 | Dexcel Pharma (Daventry)
|
| 52 | CST Pharma (Walsall)
|
| 53 | Cipla Eu (Addlestone)
|
| 54 | Relonchem (Widnes)
|
| 55 | RPH Pharmaceuticals (Cheadle)
|
| 56 | Drugsrus (Northwood)
|
| 57 | Ferring Pharmaceuticals (West Drayton)
|
| 58 | Milpharm (South Ruislip)
|
| 59 | Crescent Pharma (Basingstoke)
|
| 60 | Roma Pharmaceuticals (Burton upon Trent)
|
| 61 | Kyowa Kirin (Galashiels)
|
| 62 | Brown & Burk (Hounslow)
|
| 63 | Lupin Healthcare (Slough)
|
| 64 | Alliance Pharmaceuticals (Chippenham)
|
| 65 | Bristol Laboratories (Berkhamsted)
|
| 66 | Aristo Pharma (Ely)
|
| 67 | Synchrony (Stevenage)
|
| 68 | Alissa Healthcare Research (Fareham)
|
| 69 | Neon Healthcare (Hertford)
|
| 70 | Aventis Pharma (Reading)
|
| 71 | Accord (Barnstaple)
|
| 72 | Acium (Stevenage)
|
| 73 | Ascend Laboratories (London)
|
| 74 | Rivopharm (London)
|
| 75 | Strides Pharma (Watford)
|
| 76 | V Pharma (Kent)
|
| 77 | Upjohn (Kent)
|
| 78 | Noumed Life Sciences (Maidenhead)
|
| 79 | Atnahs Pharma (London)
|
| 80 | Phoenix Lab (None)
|
| 81 | Sciecure Pharma (Guildford)
|
| 82 | Intrapharm Laboratories (Maidenhead)
|
| 83 | Typharm (Norwich)
|
| 84 | Oralieve (Luton)
|
| 85 | Flynn Pharma (None)
|
| 86 | Takeda (London)
|
| 87 | Beaumont Pharma (Burnley)
|
| 88 | Tillomed Laboratories (Luton)
|
| 89 | Focus Pharmaceuticals (London)
|
| 90 | Galen (Co Armagh)
|
| 91 | Clydesdale Pharma (Tadley)
|
| 92 | Medley Pharma (Bootle)
|
| 93 | Mibe Pharma (London)
|
| 94 | Transdermal (Berkshire)
|
| 95 | Ipca Laboratories (Sunderland)
|
| 96 | Necessity Supplies (Northolt)
|
| 97 | Ferndale Pharmaceuticals (Wetherby)
|
| 98 | Pfizer (Kent)
|
| 99 | Merck Sharpe & Dohme (London)
|
| 100 | Medreich (Weybridge)
|
| 101 | Ennogen Healthcare (Dartford)
|
| 102 | Glaxosmithkline (London)
|
| 103 | Hameln Pharma (Gloucester)
|
| 104 | Medac Pharma (Stirling)
|
| 105 | Martindale Pharma (Romford)
|
| 106 | Mercury Pharmaceuticals (London)
|
| 107 | Selective Supplies (London)
|
| 108 | Nexcape Pharmaceuticals (London)
|
| 109 | Consilient Health (Richmond upon Thames)
|
| 110 | Sandoz (Camberley)
|
| 111 | Fresenius Kabi (Runcorn)
|
| 112 | Glenmark Pharmaceuticals Europe (Watford)
|
| 113 | Laboratorio Reig Jofre (Bideford)
|
| 114 | Kent Pharma (Heathrow)
|
| 115 | Bowmed Ibisqus (Manchester)
|
| 116 | Panpharma (Liverpool)
|
| 117 | Kensington Pharma (Preston)
|
| 118 | Thornton & Ross (Huddersfield)
|
| 119 | Mylan (Potters Bar)
|
| 120 | Macleods Pharma (Billingham)
|
| 121 | Wockhardt (Wrexham)
|
| 122 | Thea Pharmaceuticals (Keele)
|
| 123 | Desitin Pharma (Woking)
|
| 124 | Stragen (Horsham)
|
| 125 | B Braun Medical (Sheffield)
|
| 126 | Torrent Pharma (Crawley)
|
| 127 | Aspire Pharma (Godalming)
|
| 128 | Teva (Castleford)
|
| 129 | Amarox (Harrow)
|
| 130 | Aop Orphan (Weybridge)
|
| 131 | Pierre Fabre (London)
|
| 132 | Macure Pharma Aps (Copenhagen)
|
| 133 | Ranbaxy (Hayes)
|
| 134 | Arcadia Pharma (Fforestfach)
|
| 135 | Drreddys Laboratories (Beverley)
|
| 136 | Aspen Pharmacare (Maidenhead)
|
| 137 | Colonis Pharma (London)
|
| 138 | Roche Products (Welwyn Garden City)
|
| 139 | Waverley Pharma Europe (None)
|
| 140 | Zentiva Pharma (London)
|
| 141 | Baxter Healthcare (Thetford)
|
| 142 | Day Lewis Medical (Croydon)
|
| 143 | Logixx Pharma (Reading)
|
| 144 | Lundbeck (Watford)
|
| 145 | Bayer (Reading)
|
| 146 | Recordati Rare Diseases (Maidenhead)
|
| 147 | Morningside Pharmaeuticals (Northampton)
|
| 148 | CST Pharma (Walsall)
|
| 149 | Cipla Eu (Addlestone)
|
| 150 | Flexipharm Austrading (Bourne End)
|
| 151 | Leo Pharma (Hurley)
|
| 152 | Aguettant (Bristol)
|
| 153 | Torbay Pharmaceuticals (Paignton)
|
| 154 | RPH Pharmaceuticals (Cheadle)
|
| 155 | Drugsrus (Northwood)
|
| 156 | Ferring Pharmaceuticals (West Drayton)
|
| 157 | Milpharm (South Ruislip)
|
| 158 | Pari (London)
|
| 159 | Kyowa Kirin (Galashiels)
|
| 160 | Brown & Burk (Hounslow)
|
| 161 | Seacross Pharmaceuticals (London)
|
| 162 | Alliance Pharmaceuticals (Chippenham)
|
| 163 | Aristo Pharma (Ely)
|
| 164 | Synchrony (Stevenage)
|
| 165 | Altan Pharma (None)
|
| 166 | Lucane Pharma (Ankeveen)
|
| 167 | Norgine Pharmaceuticals (Uxbridge)
|
| 168 | Neon Healthcare (Hertford)
|
| 169 | Aventis Pharma (Reading)
|
| 170 | Mip Pharma (Blieskastel Niederwuerzbach)
|
| 171 | Accord (Barnstaple)
|
| 172 | Ascend Laboratories (London)
|
| 173 | Rivopharm (London)
|
| 174 | Strides Pharma (Watford)
|
| 175 | Atnahs Pharma (London)
|
| 176 | Sobi Swedish Orphan Biovitrum (Great Abington)
|
| 177 | Phoenix Lab (None)
|
| 178 | Intrapharm Laboratories (Maidenhead)
|
| 179 | Flynn Pharma (None)
|
| 180 | Tetris Pharma (Northampton)
|
| 181 | Sintetica (London)
|
| 182 | Tillomed Laboratories (Luton)
|
| 183 | Alturix (Milton Keynes)
|
| 184 | Euro Link Pharma (Luton)
|
| 185 | Vantage Pharmaceuticals (Hemel Hempstead)
|
| 186 | Focus Pharmaceuticals (London)
|
| 187 | Chiesi (Manchester)
|
| 188 | PM Pharma (Norwich)
|
| 189 | Correvio (Bielefeld)
|
| 190 | Waymade (London)
|
| 191 | Recordati Pharmaceuticals (Bracknell)
|
| 192 | Northumbria Pharma (County Durham)
|
Renewal Options
Option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-02be28
- FTS 001128-2022